|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-18
|
$312,561
|
$312,561
|
Boland, Clement
|
BAYLOR RESEARCH INSTITUTE
|
|
|
A National Curriculum in Cancer Genomics for Pathology Residents
|
5R25CA168544-02
|
$281,311
|
$140,656
|
Haspel, Richard
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
3R01CA079830-12S1
|
$64,824
|
$64,824
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-12
|
$300,984
|
$300,984
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
|
Molecular Pathoepidemiology of Endometrial Cancer Risk
|
5R01CA082838-11
|
$403,462
|
$403,462
|
devivo, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Validation of Genomic Targets in Melanoma
|
5R01CA114337-09
|
$323,587
|
$323,587
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
|
Breast Cancer Family Registry Cohort
|
5UM1CA164920-02
|
$2,258,395
|
$1,129,198
|
JOHN, ESTHER
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
|
Cytogenetic and Molecular Studies of Chromosome 22
|
5R01CA039926-25
|
$344,242
|
$344,242
|
EMANUEL, BEVERLY
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
2R01CA124709-06
|
$630,730
|
$630,730
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
THE PATHOGENESIS OF DYSKERATOSIS CONGENITA
|
5R01CA106995-09
|
$294,585
|
$294,585
|
MASON, PHILIP
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-05
|
$311,233
|
$155,617
|
Mosse, YAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome
|
5R01CA143167-04
|
$325,381
|
$325,381
|
Hill, Dana
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
2P30CA033572-30
|
$2,042,489
|
$20,425
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S1
|
$125,000
|
$1,250
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S2
|
$52,354
|
$524
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S3
|
$10,680
|
$107
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
CpG methylation and mutation
|
5R01CA084469-14
|
$266,077
|
$266,077
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S3
|
$3,546,194
|
$283,696
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S4
|
$75,000
|
$6,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S5
|
$125,000
|
$10,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S6
|
$49,718
|
$3,977
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations
|
5K07CA151769-04
|
$171,180
|
$171,180
|
Kastrinos, Fay
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Genes, environment and breast cancer risk: The 15 year follow-up of the Prof-SC
|
5R01CA159868-03
|
$1,850,683
|
$1,850,683
|
TERRY, MARY BETH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
DF/HCC SPORE in Prostate Cancer
|
2P50CA090381-11A1
|
$2,150,500
|
$881,705
|
KANTOFF, PHILIP
|
DANA-FARBER CANCER INST
|
|
|
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer
|
2R01CA132829-05
|
$424,662
|
$106,166
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INST
|
|
|
The Genetics and Prevention of Gastrointestinal Cancers
|
5K24CA113433-09
|
$196,841
|
$196,841
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INST
|
|
|
Cohort Study of Biochemical and Genetic Risk Factors for Pancreatic Cancer
|
5K07CA140790-05
|
$178,110
|
$53,433
|
Wolpin, Brian
|
DANA-FARBER CANCER INST
|
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
5U19CA148127-04
|
$2,389,224
|
$2,078,625
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
|
MicroRNA Related Genetic Variation in Bladder Cancer Recurrence and Survival
|
1R21CA175553-01
|
$175,903
|
$175,903
|
Christensen, Brock
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
3P30CA023108-35S1
|
$12,500
|
$2,375
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
3P30CA023108-35S2
|
$50,000
|
$9,500
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
5P30CA023108-35
|
$2,922,577
|
$555,290
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-39S1
|
$18,744
|
$375
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-39
|
$5,351,774
|
$107,035
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
|
Atlantic Breast and Gynecologic Clinical Validation Center
|
5U01CA084955-14
|
$468,371
|
$468,371
|
Marks, Jeffrey
|
DUKE UNIVERSITY
|
|
|
Adult Leukemia Research Center
|
5P01CA018029-38
|
$3,971,921
|
$476,631
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S1
|
$109,383
|
$4,375
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S2
|
$18,750
|
$750
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S3
|
$125,000
|
$5,000
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S4
|
$50,000
|
$2,000
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-39
|
$10,072,717
|
$402,909
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Telomeres and lung cancer incidence and survival
|
5R01CA151989-03
|
$528,941
|
$528,941
|
Doherty, Jennifer
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
5R01CA054498-22
|
$637,769
|
$127,554
|
LEISENRING, WENDY
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Development of a comprehensive model for colorectal cancer risk prediction
|
5R01CA170122-02
|
$277,734
|
$277,734
|
Newcomb, Polly
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Evolution of cancer-specific molecular requirements for glioblastoma multiforme (
|
5R21CA170722-02
|
$176,645
|
$176,645
|
Paddison, Patrick
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Clinical Significance of MHC Haplotypes in HCT
|
2R01CA100019-11
|
$336,873
|
$336,873
|
Petersdorf, Effie
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Impact Of Genomic and Personalized Medicine in Women Under 65 With Breast Cancer
|
5R01CA160671-02
|
$339,891
|
$339,891
|
Potosky, Arnold
|
GEORGETOWN UNIVERSITY
|
|
|
INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS
|
5R01CA135179-05
|
$355,097
|
$355,097
|
Schwartz, Marc
|
GEORGETOWN UNIVERSITY
|
|
|
Adolescents' Long-Term Adaptation to Familial Cancer Risks
|
5R01CA137625-04
|
$538,281
|
$538,281
|
TERCYAK, KENNETH
|
GEORGETOWN UNIVERSITY
|
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
3P30CA051008-20S1
|
$43,750
|
$4,813
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Total relevant funding to Genetic Testing for this search: $63,365,420
|
